Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Cazzola, M. Miravitlles, C. Vogelmeier, M. Partridge, D. Leynaud, J. Ostinelli, R. Kessler (Rome, Italy; Barcelona, Spain; Marburg, Germany; London, United Kingdom; Rueil-Malmaison, Strasbourg, France). Gender-specific differences in symptoms among patients with severe COPD. Eur Respir J 2010; 36: Suppl. 54, 569

Member's Comments

No comment yet.

Related content which might interest you: Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 Gender differences in hospitalised COPD patients Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010 Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 What are the differences between moderate and severe COPD exacerbation groups? Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Clinical phenotypic differences between COPD and asthma in elderly patients Source: Eur Respir J 2004; 24: Suppl. 48, 60s Year: 2004 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Gender differences in exertional breathlessness in patients with mild COPD Source: Annual Congress 2007 - Advances in respiratory muscles Year: 2007 Gender differences in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Gender differences of echocardiographic characteristics in patients with acute exacerbation of COPD Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Relationship between pharmacotherapy and severity of disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 73s Year: 2007 Cardiovascular comorbidity in severe COPD patients Source: International Congress 2017 – Markers of COPD progression Year: 2017 Relationship of anxiety and depression with sociodemographic characteristics in hospitalized patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care Year: 2018 GERD and anxiety in patients with severe COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Characterising symptom ‘trajectotypes’ in patients with COPD Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Prevalence of comorbidities in patients with COPD in south-Spain Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Drivers of respiratory symptoms in COPD patients Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 Are comorbidities related to frequent severe exacerbations of COPD? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019